Help Your Patients Control Asthma Symptoms
QVAR® is a long-term control medication for asthma.1 QVAR® provides good lung deposition, even among adults with poor inhaler technique.2 QVAR® doesn't need shaking and can be used with or without a spacer,1 making it a good choice for a wide range of patients, including children as young as 5 years old.1
Patients Can Use QVAR® With or Without Spacers
QVAR® can be used with or without a spacer.1 Potential benefits of using QVAR® without a spacer include:
- Eliminating the cost of a spacer
- No need to train patients on spacer use and cleaning
- 54% lung deposition without a spacer in children 11-14 years of age.3
Consider QVAR® for patients who are transitioning from a nebulizer.
Learn More About QVAR®
Read on for important information about QVAR® dosing in adults and children, helping patients maintain adherence, and initiating asthma control therapy with QVAR® for patients with mild to moderate persistent asthma.
QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age or older. QVAR® is also indicated for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.
Important Safety Information
- QVAR® is not a bronchodilator and is not indicated for relief of acute bronchospasm
- Common side effects associated with the use of QVAR® and placebo in clinical trials include, but are not limited to, headache (12% and 9%, respectively) and pharyngitis (8% and 4%, respectively)
CAUTION: Adrenal insufficiency may occur when transferring patients from systemic steroids (see WARNINGS, Prescribing Information).
- A reduction in growth velocity in growing children and teenagers may occur as a result of inadequate control of chronic diseases such as asthma or from use of corticosteroids for treatment